Skip to main content

Lassie: The first-ever painless breath analyser for people with diabetes, a breakthrough in blood glucose monitoring

Project description

Diabetes management, just a breath away

Trained sniffer dogs can be used to detect people with high and low blood glucose, cancer and COVID-19. Inspired by the power of a dog’s nose, the Lassie breath analyser is a new device by the European Innovation Council BOYDSence. It’s the first non-invasive diabetes monitoring technology to use breath-based biomarkers to predict glucose levels. Current glucose monitoring technologies are underused because they are highly invasive, expensive, stigmatising and generate a lot of waste. With Lassie, all users need is to download a smartphone app and breathe into the device. By analysing volatile organic compounds in the breath, Lassie will calculate blood glucose value within current accuracy standards. Users will test earlier and more.

Coordinator

BOYDSENSE
Net EU contribution
€ 2 500 000,00
Address
4 Rue Brindejonc Des Moulinais
31500 Toulouse
France

See on map

Region
Occitanie Midi-Pyrénées Haute-Garonne
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 8 346 250,00